New study tracks vision loss in rare eye disease to guide future treatments

NCT ID NCT05573984

First seen Apr 17, 2026 · Last updated May 14, 2026 · Updated 2 times

Summary

This study follows 50 people with a genetic eye condition called PRPF31-related retinal dystrophy (RP11) to understand how their vision changes over time. Researchers will measure things like visual sharpness, retinal thickness, and daily function using eye exams and patient questionnaires. The goal is to learn more about the disease's natural course, which can help design better treatments in the future.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Centre For Eye Research Australia (CERA) - Retinal Gene Therapy Unit

    East Melbourne, Australia

  • Lions Eye Institute

    Nedlands, Western Australia, 6009, Australia

  • Oregon Health and Science University - Casey Eye Institute

    Portland, Oregon, 97239, United States

  • Retina Foundation of the Southwest

    Dallas, Texas, 75321, United States

  • University of California San Francisco

    San Francisco, California, 94143, United States

  • University of Florida Health

    Jacksonville, Florida, 32209, United States

  • University of Michigan Kellogg Eye Center

    Ann Arbor, Michigan, 48105, United States

Conditions

Explore the condition pages connected to this study.